New MT2 Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New MT2 Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 7, Pages 1347
Publisher
MDPI AG
Online
2017-06-23
DOI
10.3390/ijms18071347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain
- (2017) Luca Posa et al. CURRENT MEDICINAL CHEMISTRY
- Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants
- (2016) Naoto Kajitani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer metastasis: Mechanisms of inhibition by melatonin
- (2016) Shih-Chi Su et al. JOURNAL OF PINEAL RESEARCH
- Detergent-free Isolation of Functional G Protein-Coupled Receptors into Nanometric Lipid Particles
- (2015) Christel Logez et al. BIOCHEMISTRY
- Quinone reductase 2 as a promising target of melatonin therapeutic actions
- (2015) Jean A Boutin EXPERT OPINION ON THERAPEUTIC TARGETS
- Tasimelteon: First Global Approval
- (2014) Sohita Dhillon et al. DRUGS
- Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
- (2014) Stefano Comai et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Pharmacological Characterization of a Highly Selective and Potent Partial Agonist of the MT2 Melatonin Receptor
- (2014) Taku Sakurai et al. PHARMACOLOGY
- Recombinant Human Melatonin Receptor MT1 Isolated in Mixed Detergents Shows Pharmacology Similar to That in Mammalian Cell Membranes
- (2014) Christel Logez et al. PLoS One
- Novel Delta Opioid Receptor Agonists with Oxazatricyclodecane Structure
- (2014) Hideaki Fujii et al. ACS Medicinal Chemistry Letters
- Melatonin MT1and MT2receptors display different molecular pharmacologies only in the G-protein coupled state
- (2013) Céline Legros et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Overview
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- New Radioligands for Describing the Molecular Pharmacology of MT1 and MT2 Melatonin Receptors
- (2013) Céline Legros et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Homology Models of Melatonin Receptors: Challenges and Recent Advances
- (2013) Daniele Pala et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Molecular and Chemical Perspective in Defining Melatonin Receptor Subtype Selectivity
- (2013) King Chan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
- (2013) Darius. P. Zlotos et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of melatonin in the cells of the innate immunity: a review
- (2013) Juan R. Calvo et al. JOURNAL OF PINEAL RESEARCH
- Biological rhythms and melatonin in mood disorders and their treatments
- (2013) Laurence Lanfumey et al. PHARMACOLOGY & THERAPEUTICS
- Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT2-selective melatonin agonists: Improving metabolic stability
- (2012) Yueqing Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors
- (2012) D. P. Zlotos CURRENT MEDICINAL CHEMISTRY
- Melatonin in Antinociception: Its Therapeutic Applications
- (2012) Venkatramanujam Srinivasan et al. Current Neuropharmacology
- Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia
- (2012) Patrick Lemoine et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Emerging Role of Melatonin Agonists in the Treatment of Major Depression: Focus on Agomelatine
- (2011) Domenico De Berardis et al. CNS & Neurological Disorders-Drug Targets
- Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?
- (2011) David J Riese Expert Opinion on Drug Discovery
- Description of the constitutive activity of cloned human melatonin receptors hMT1 and hMT2 and discovery of inverse agonists
- (2011) Séverine Devavry et al. JOURNAL OF PINEAL RESEARCH
- Recent advances in the development of melatonin MT1and MT2receptor agonists
- (2010) Marco Mor et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
- (2010) Christian de Bodinat et al. NATURE REVIEWS DRUG DISCOVERY
- High-throughput screening assay for new ligands at human melatonin receptors
- (2009) Jian-hua Yan et al. ACTA PHARMACOLOGICA SINICA
- The end of a myth: cloning and characterization of the ovine melatonin MT2 receptor
- (2009) F Cogé et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat
- (2008) Simon P. Fisher et al. JOURNAL OF PINEAL RESEARCH
- Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion
- (2008) Valeriya Lyssenko et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started